Latha Vairavan | executive |
Frank Watanabe | executive |
Todd Edwards | executive |
Patrick Burnett | executive |
David Topper | executive |
Tyler Van Buren | analyst |
Seamus Fernandez | analyst |
Uy Ear | analyst |
Serge Belanger | analyst |
Chris Shibutani | analyst |
Hello, and thank you for standing by. Welcome to Arcutis BioTherapeutics Q2 2024 Earnings Call. [Operator Instructions] After the speakers' presentation, there will be a question and answer session. I would now like to turn the call over to Latha Vairavan, Vice President, Finance and Investor Relations.
Thank you, Towanda.